National Peroxide Ltd has deferred its Board Meeting scheduled for August 03, 2026, which was convened to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The company informed the Bombay Stock Exchange on August 02, 2026, that the meeting has been postponed due to unavoidable circumstances. Investors seeking clarity on the firm’s performance in Q1FY26 must now wait for a revised date, which the company stated it would communicate to the stock exchange in due course as per regulatory requirements.

The deferment impacts the timeline for the release of quarterly financials, a key metric for market participants tracking the chemical manufacturer’s operational health. National Peroxide Limited, formerly known as NPL Chemicals Limited, had initially notified stakeholders of the meeting via an intimation dated July 29, 2026. The company did not specify the nature of the unavoidable circumstances leading to the postponement.

Regulatory Compliance and Trading Window

In compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company updated the exchange regarding the change in schedule. The original notice under the Listing Regulations had set August 03 as the date for the board to review the quarterly performance.

Consequent to the deferment, the trading window in respect of the company’s securities remains closed for all designated persons and their immediate relatives. This restriction, which began on July 01, 2026, will continue until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. This ensures that insiders do not trade while in possession of unpublished price-sensitive information regarding the Q1FY26 results.

Key Details

Akshay Satasiya, Company Secretary and Compliance Officer, signed the intimation filed with the BSE Limited. The company’s scrip code is 544205. No further details regarding the specific agenda items or expected outcomes of the deferred meeting were provided in the filing.

National Peroxide Ltd has accepted the resignation of Rajeev Pradhan from the position of Chief Information Officer effective July 15, 2026. The resignation, attributed to personal reasons, was submitted to the Board of Directors and is effective from the close of business hours on the stated date. This change in senior management was disclosed to the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company confirmed that the resignation letter has been received and the necessary formalities will be completed. The disclosure was filed with BSE Limited under the scrip code 544205. The information regarding the change was detailed in an annexure provided to the exchange, specifying the reason for the cessation and the effective date.

Details of the Change

The following table outlines the key details regarding the change in senior management at National Peroxide Ltd:

The resignation was tendered by Rajeev Pradhan from Kalyan. In his resignation letter, he expressed gratitude to the management, colleagues, and stakeholders for their support during his tenure with the company. The Board of Directors has been requested to note the resignation and complete the requisite formalities.